PCL Research & Manufacturing s.r.l. provides reliable solutions to optimise and control the crystallisation process of Active Pharmaceutical Ingredients for pharmaceutical companies — since 2005.
Our mission is to support our clients during drug development, helping them to reduce batch failure, avoid costly crystallisation issues and overall offer greater confidence in drug quality. We can support you from early-phase drug discovery to kilogram-scale non-GMP supply.
We are a high-performing, cohesive team of trained chemists and analysts, with more than 20 years of experience in the development and optimization of APIs crystallization.
We care about results and innovation based on sound science and the use of modern technologies.
Our laboratories are equipped with state-of-the-art instruments covering the complete range of solid-state and physicochemical characterization at a glance.
Our analytical facility and processes operate under strict regulatory compliance, providing pharmaceutical companies worldwide with complete confidence.
FDA-inspected test facility for the analysis of pharmaceutical products, confirming adherence to international quality standards.
Our analytical department is certified to work according to GMP by AIFA. The GMP certification includes X-ray powder diffraction (quantitative/qualitative), FT-Raman, FT-IR and PSD.
PCL R&M received authorization from the Italian Ministry of Health for the study, production and chemical/physical analysis of controlled substances.
Our team of expert chemists and analysts is ready to support your drug development — from early-phase screening to non-GMP development and manufacturing.